Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis
BackgroundLevetiracetam (LEV) and oxcarbazepine (OXC) are new antiseizure medications (ASMs). In recent years, OXC monotherapy is widely used in children with epilepsy; however, no consensus exists on applying LEV monotherapy among children with epilepsy.ObjectiveThe present work focused on comparin...
Saved in:
Main Authors: | Yuanyuan Liu (Author), Yanxu Wang (Author), Xingzhou Li (Author), Xiaomin Wu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy
by: Jiahong Wang
Published: (2023) -
Efficacy of levetiracetam in refractory childhood epilepsy
by: Keon Su Lee, et al.
Published: (2010) -
Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis
by: Jing Peng, et al.
Published: (2024) -
Risk-Benefits of Oxcarbazepine vs Carbamazepine
by: J Gordon Millichap
Published: (2004) -
Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
by: Jaydeep Sinha, et al.
Published: (2022)